Surfactant-Free Solid Dispersions of Hydrophobic Drugs in an Amorphous Sugar Matrix Dried from an Organic Solvent

被引:21
作者
Takeda, Koji [2 ]
Gotoda, Yuto [2 ]
Hirota, Daichi [2 ]
Hidaka, Fumihiro [2 ]
Sato, Tomo [2 ]
Matsuura, Tsutashi [1 ]
Imanaka, Hiroyuki [2 ]
Ishida, Naoyuki [2 ]
Imamura, Koreyoshi [2 ]
机构
[1] Okayama Univ, Grad Sch Nat Sci & Technol, Div Chem & Biochem, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan
[2] Mitsubishi Kagaku Foods Co, Aoba Ku, 1000 Kamoshida Cho, Yokohama, Kanagawa 2278502, Japan
关键词
solid dispersion; amorphous sugar; surfactant-free; hydrophobic drug; vacuum foam drying; GLASS-TRANSITION; DELIVERY SYSTEMS; BIOAVAILABILITY; DISSOLUTION; SOLUBILITY; CLASSIFICATION; CARRIERS; ABSORPTION; POLYMERS; BEHAVIOR;
D O I
10.1021/acs.molpharmaceut.6b01048
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The technique for homogeneously dispersing hydrophobic drugs in a water-soluble solid matrix (solid dispersion) is a subject that has been extensively investigated in the pharmaceutical industry. Herein, a novel technique for dispersing a solid, without the need to use a surfactant, is reported. A freeze-dried amorphous sugar sample was dissolved in an organic solvent, which contained a soluble model hydrophobic component. The suspension of the sugar and the model hydrophobic component was vacuum foam dried to give a solid powder. Four types of sugars and methanol were used as representative sugars and the organic medium. Four model drugs (indomethacin, ibuprofen, gliclazide, and nifedipine) were employed. Differential scanning calorimetry analyses indicated that the sugar and model drug (100:1) did not undergo segregation during the drying process. The dissolution of the hydrophobic drugs in water from the solid dispersion was then evaluated, and the results indicated that the C-max and AUC(0-60) (min) of the hydrophobic drug in water were increased when the surfactant-free solid dispersion was used. Palatinose and/or alpha-maltose were superior to the other tested carbohydrates in increasing C-max and AUC(0-60 min), for all tested model drugs, and the model drug with a lower water solubility tended to exhibit a greater extent of over-dissolution.
引用
收藏
页码:791 / 798
页数:8
相关论文
共 48 条
[1]  
Amidon G. L., 1991, TECHNIQUES SOLUBILIZ, P183
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]   SUBMICRON EMULSIONS AS COLLOIDAL DRUG CARRIERS FOR INTRAVENOUS ADMINISTRATION - COMPREHENSIVE PHYSICOCHEMICAL CHARACTERIZATION [J].
BENITA, S ;
LEVY, MY .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (11) :1069-1079
[4]   Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability? [J].
Brouwers, Joachim ;
Brewster, Marcus E. ;
Augustijns, Patrick .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (08) :2549-2572
[5]  
Chadha R, 2006, J SCI IND RES INDIA, V65, P459
[6]   Influence of glucose solubility and dissolution rate on the kinetics of lipase catalyzed synthesis of glucose laurate in 2-methyl 2-butanol [J].
Flores, MV ;
Naraghi, K ;
Engasser, JM ;
Halling, PJ .
BIOTECHNOLOGY AND BIOENGINEERING, 2002, 78 (07) :814-820
[7]   Characterization of Supersaturatable Formulations for Improved Absorption of Poorly Soluble Drugs [J].
Gao, Ping ;
Shi, Yi .
AAPS JOURNAL, 2012, 14 (04) :703-713
[8]   What is the true solubility advantage for amorphous pharmaceuticals? [J].
Hancock, BC ;
Parks, M .
PHARMACEUTICAL RESEARCH, 2000, 17 (04) :397-404
[9]   Fundamental aspects of solid dispersion technology for poorly soluble drugs [J].
Huang, Yanbin ;
Dai, Wei-Guo .
ACTA PHARMACEUTICA SINICA B, 2014, 4 (01) :18-25
[10]   Maintaining Supersaturation in Aqueous Drug Solutions: Impact of Different Polymers on Induction Times [J].
Ilevbare, Grace A. ;
Liu, Haoyu ;
Edgar, Kevin J. ;
Taylor, Lynne S. .
CRYSTAL GROWTH & DESIGN, 2013, 13 (02) :740-751